Home / Cancer and immune system / Encorafenib
ATC L01EC03 · Antineoplastic Agents
Encorafenib shortage
As of 31 Oct 2026, Encorafenib has a reported shortage in 2 of the 5 countries we track (Germany, Austria), covering 2 products.
Countries2/5
Products2packs or presentations
Short since29 Oct 20262 days ago
Earliest return15 Nov 2026company estimate
No return date0products
Main reasonIncreased demand
Timeline
GermanyAustria
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Braftovi 50 mg Hartkapseln announced | Pierre Fabre Medicament | 2 Nov 2026 | 15 Nov 2026 | Increased demand Erhöhte Nachfrage |
| AT | Braftovi 75 mg Hartkapseln, 168 Stück | Pierre Fabre Medicament | 29 Oct 2026 | 15 Dec 2026 | Increased demand Erhöhter Mehrbedarf |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.